Selecting the right consultant or PMC partner is the single highest-leverage decision in your project. Brand names matter less than execution depth — here is the evaluation framework we recommend to every promoter and plant head.
1. Execution Track Record
Ask for projects of similar scope, similar geography, similar regulatory exposure. Visit at least two reference sites. Talk to plant heads — not just promoters.
2. Team Composition
- Who will actually work on your project — and what is their pharma background?
- Is the senior engineer hands-on or only at kick-off?
- Is the team in-house or freelancer-stitched?
3. Technical Depth
Ask design-stage technical questions. The right consultant will discuss pressure cascades, dead legs, classification rationale, and validation strategy in your first meeting — not slides.
4. Audit Exposure
Has the team supported USFDA, EU cGMP, WHO, MHRA, or PMDA audits? Has any facility they designed received critical observations? How were they resolved?
5. Working Style Fit
- Transparent decision documentation
- Willingness to escalate issues early
- Comfortable with promoter-driven environments
- Strong vendor pushback capability when needed
6. Commercial Clarity
Fixed-fee, time-and-material, or success-fee? Each model creates different incentives. Make sure the model aligns with your project complexity.
Red Flags
- Generic proposals with no project-specific insight
- Heavy reliance on subcontractors for core work
- Reluctance to share past audit outcomes
- One-size-fits-all engagement models
Conclusion
The right consultant is not the cheapest, the largest, or the most marketed. It is the one whose senior team will stand next to you when the audit happens.
At H&G, we welcome detailed evaluation. Contact us for a project-specific capability discussion.